IL6 and Alzheimer disease: Notably, enhanced levels of IL-1β induces the production of other cytokines, including IL-6, which in turn promotes the activation of the kinase CDK5 that hyper-phosphorylates tau, further promoting AD progression (Rauf et al., 2022).